Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hypertension, Portal 2Liver Diseases 1Liver Cirrhosis 1Gastrointestinal Neoplasms 1Carcinoma, Hepatocellular 1Ascites 1

Interventions

Drug Therapy 4apatinib 3Oxaliplatin 3Leucovorin 3Irinotecan 3Fluorouracil 3pemigatinib 2pembrolizumab 2cemiplimab 2avelumab 2atezolizumab 2S 1 (combination) 2Nivolumab 2Folfox protocol 2Everolimus 2Erlotinib Hydrochloride 2Endoscopic Mucosal Resection 2Docetaxel 2Capecitabine 2CGX1321 2Bevacizumab 2vandetanib 1titanium silicide 1tepotinib 1tegafur-gimeracil-oteracil 1talazoparib 1sodium thiosulfate 1selpercatinib 1rucaparib 1pralsetinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Gastrointestinal Neoplasms × Portasystemic Shunt, Transjugular Intrahepatic × Clear all
NCT05141617 2021-12-02

Management of Oxaliplatin-related Gastroesophageal Variceal Bleeding

Shanghai Zhongshan Hospital

Phase NA Unknown
100 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Hypertension, Portal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡